496 related articles for article (PubMed ID: 23807371)
1. Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial.
Bressler SB; Qin H; Melia M; Bressler NM; Beck RW; Chan CK; Grover S; Miller DG;
JAMA Ophthalmol; 2013 Aug; 131(8):1033-40. PubMed ID: 23807371
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation.
; Googe J; Brucker AJ; Bressler NM; Qin H; Aiello LP; Antoszyk A; Beck RW; Bressler SB; Ferris FL; Glassman AR; Marcus D; Stockdale CR
Retina; 2011 Jun; 31(6):1009-27. PubMed ID: 21394052
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
; Elman MJ; Aiello LP; Beck RW; Bressler NM; Bressler SB; Edwards AR; Ferris FL; Friedman SM; Glassman AR; Miller KM; Scott IU; Stockdale CR; Sun JK
Ophthalmology; 2010 Jun; 117(6):1064-1077.e35. PubMed ID: 20427088
[TBL] [Abstract][Full Text] [Related]
4. Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema.
Bressler SB; Glassman AR; Almukhtar T; Bressler NM; Ferris FL; Googe JM; Gupta SK; Jampol LM; Melia M; Wells JA;
Am J Ophthalmol; 2016 Apr; 164():57-68. PubMed ID: 26802783
[TBL] [Abstract][Full Text] [Related]
5. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Elman MJ; Bressler NM; Qin H; Beck RW; Ferris FL; Friedman SM; Glassman AR; Scott IU; Stockdale CR; Sun JK;
Ophthalmology; 2011 Apr; 118(4):609-14. PubMed ID: 21459214
[TBL] [Abstract][Full Text] [Related]
6. Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation.
Bressler NM; Edwards AR; Beck RW; Flaxel CJ; Glassman AR; Ip MS; Kollman C; Kuppermann BD; Stone TW;
Arch Ophthalmol; 2009 Dec; 127(12):1566-71. PubMed ID: 20008708
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results.
; Elman MJ; Qin H; Aiello LP; Beck RW; Bressler NM; Ferris FL; Glassman AR; Maturi RK; Melia M
Ophthalmology; 2012 Nov; 119(11):2312-8. PubMed ID: 22999634
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Dewan V; Lambert D; Edler J; Kymes S; Apte RS
Ophthalmology; 2012 Aug; 119(8):1679-84. PubMed ID: 22503301
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.
Diabetic Retinopathy Clinical Research Network*
JAMA Ophthalmol; 2013 Mar; 131(3):283-93. PubMed ID: 23370902
[TBL] [Abstract][Full Text] [Related]
10. Practical Lessons from Protocol I for the Management of Diabetic Macular Edema.
Mukkamala L; Bhagat N; Zarbin MA
Dev Ophthalmol; 2017; 60():91-108. PubMed ID: 28427069
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy.
Ip MS; Domalpally A; Sun JK; Ehrlich JS
Ophthalmology; 2015 Feb; 122(2):367-74. PubMed ID: 25439595
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results.
Elman MJ; Ayala A; Bressler NM; Browning D; Flaxel CJ; Glassman AR; Jampol LM; Stone TW;
Ophthalmology; 2015 Feb; 122(2):375-81. PubMed ID: 25439614
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of masking study participants to intravitreal injections in a randomized clinical trial.
Glassman AR; Stockdale CR; Beck RW; Baker C; Bressler NM;
Arch Ophthalmol; 2012 Feb; 130(2):190-4. PubMed ID: 22332211
[TBL] [Abstract][Full Text] [Related]
15. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema.
Soheilian M; Garfami KH; Ramezani A; Yaseri M; Peyman GA
Retina; 2012 Feb; 32(2):314-21. PubMed ID: 22234244
[TBL] [Abstract][Full Text] [Related]
16. Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema.
Zein WM; Noureddin BN; Jurdi FA; Schakal A; Bashshur ZF
Retina; 2006 Feb; 26(2):137-42. PubMed ID: 16467667
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of ranibizumab on diabetic retinopathy severity and progression.
Ip MS; Domalpally A; Hopkins JJ; Wong P; Ehrlich JS
Arch Ophthalmol; 2012 Sep; 130(9):1145-52. PubMed ID: 22965590
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab.
Bressler SB; Qin H; Beck RW; Chalam KV; Kim JE; Melia M; Wells JA;
Arch Ophthalmol; 2012 Sep; 130(9):1153-61. PubMed ID: 22965591
[TBL] [Abstract][Full Text] [Related]
19. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Gross JG; Glassman AR; Liu D; Sun JK; Antoszyk AN; Baker CW; Bressler NM; Elman MJ; Ferris FL; Gardner TW; Jampol LM; Martin DF; Melia M; Stockdale CR; Beck RW;
JAMA Ophthalmol; 2018 Oct; 136(10):1138-1148. PubMed ID: 30043039
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network
Ophthalmology; 2008 Sep; 115(9):1447-9, 1449.e1-10. PubMed ID: 18662829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
